MD, Medical Oncologist / PhD student CNRS UMR5095 / Université et CHU de Bordeaux 🇲🇫
Bordeaux, France
- Tweets 49
- Following 279
- Followers 141
- Likes 442
Mathieu Larroquette retweeted
Une revue très exhaustive des cancers du poumon survenant chez les patients jamais fumeurs #LCINS ,Caracteristiques,Facteurs de risque et méthodes diagnostiques
@NatRevClinOncol
nature.com/articles/s41571-0…
1
4
9
972
Mathieu Larroquette retweeted
UK bowel cancer death rates forecast to rise by third among under-50s (@Annals_Oncology @myESMO) theguardian.com/society/2024…
2
5
4
1,421
Happy to have contributed to this collaborative work from GETUG about the characteristics of GI metastases in patients w. RCC : presentation, prognosis and ttt.
Thank you @FlorianCarneiro and @matcancel for conducting this study!
@MarineGrossGoupil
ejcancer.com/article/S0959-8…
1
11
262
👏@audrey_burban & @SharanekAhmad for having conducted this work exploiting a metabolic vulnerability in GBM. Proud to be part of the story! Let's continue to work together for a better understanding of glioblastoma oncogenesis with @CHUBordeaux @Thomas_Daubon @univbordeaux
Happy to see this story out! Thanks to all collaborators and thanks to the brilliant PhD students @tessier_cloe, Mathis Pinglaut, Johanna Galvis & @MathieuLrqt
1
6
500
Mathieu Larroquette retweeted
The @myESMO LBAs are out
And a wow for PEMBRO/EV (Presidential)
OS 31.5 vs 16.1 months (HR 0.45)
PFS 12.5 vs 6.3 months (HR 0.47)
P<0.00001
A historic change for 1L mUC since Von Der Maase JCO 2000
@tompowles1 #ESMO23 @OncoAlert
18
141
393
86,714
Mathieu Larroquette retweeted
Today our important study on air pollutants in the promotion of lung cancer has been published in @Nature led by @WillHilliam @LimEmilia @DrClareWeeden @SwantonLab ...Thread below🧵nature.com/articles/s41586-0…
67
1,157
2,609
727,699
Mathieu Larroquette retweeted
✨ Just out in @Annals_Oncology! Our prospective study evaluating the impact of comprehensive molecular profiling of ctDNA in patients with advanced solid tumors. @GustaveRoussy @myESMO doi.org/10.1016/j.annonc.202…
2
6
14
1,620
Metastatic ccRCC : we discuss current treatment modalities, new approaches such as escalation/de-escalation strategies and innovative drugs in our last review article in @Cancers_MDPI
mdpi.com/2072-6694/14/24/623…
@LefortFelix
@CHUBordeaux
@OncoAlert
2
2
14
1,282
Mathieu Larroquette retweeted
Comme chaque mois de novembre c est l occasion de rappeler l importance des dépistage #cancer #prostate #testicule et de se faire de belle moustache !!!
1
6
32
Ces images et l'impuissance qu'elles procurent sont un déchirement. Plus qu'un patrimoine, c'est la terre de toute ma jeunesse qui part en fumée. Pensées émues et soutien aux proches et à tous les habitants du #bassindarcachon. Merci aux #pompiers pour leur dévouement remarquable
11
Mathieu Larroquette retweeted
Clinical outcome measures in patients with soft-tissue #sarcomas are better following #anti-PD-1 treatment in a cohort prospectively selected for the presence of intratumoral tertiary lymphoid structures. @AItalianoMD #NMEDClinical #immunotherapy
nature.com/articles/s41591-0…
8
24
Mathieu Larroquette retweeted
[MOVEMBER approche 📣] MERCI 🙏à @UBBrugby qui réalisera des actions de sensibilisation samedi soir à l'occasion du match @UBBrugby VS #Clermont et au Dr @amaury_daste, oncologue au @CHUBordeaux qui fera le coup d'envoi fictif du match en soutien à Movember !🏉! A vos moustache👨
2
11
50
Combining chemotherapy with ICI in advanced solid tumours : rationale, efficacy and perspectives are discussed in our last review article published in EJC. Check it out! ⤵️
@amaury_daste @LefortFelix @AmandineQuivy @OncoAlert @CHUBordeaux
ejcancer.com/article/S0959-8…
2
3
14
Mathieu Larroquette retweeted
Le molnupiravir réduirait de 50% le risque d'hospitalisation ou décès
merck.com/news/merck-and-rid…
Si c'est confirmé cela serait utile même si on peut avoir des craintes sur son activité mutagène
Rappelons que le vaccin réduit de plus de 90% ce risque en toute sécurité
Vaccinez vous
1
6
23
Mathieu Larroquette retweeted
🔥The August issue @NatureCancer is out!🔥
Read about TLS and #immunotherapy in solid tumors, advances in #CART cell therapy, #TumorImmunology in prostate cancer, #chemotherapy and #leukemia relapse & more! Check the😍cover!
Find the full issue 👇👇
go.nature.com/3DkdrT8
46
161
Mathieu Larroquette retweeted
📯 Congrats for this collaborative work led by Antoine Italiano! Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression, opening new insights into IO! @BERGONIE33 @GustaveRoussy nature.com/articles/s43018-0…
2
6
16
Mathieu Larroquette retweeted
Mais que veulent ces gens ?… que les professionnels de santé arrêtent de travailler, de soigner, de protéger ???
« Assassin », « collabo », des manifestants s’en prennent au pharmacien réalisant des tests de dépistage rue de Maguelone à Montpellier. #manif31juillet (1/2)
32
65
317
Mathieu Larroquette retweeted
New Platinum Opinion from @FlorentPeyraud @MathieuLrqt Alain Ravaud and Marine Gross-Goupil
New Insights into Adjuvant Therapy in Renal Cell Carcinoma: Is the Chapter of VEGF Inhibitors Definitely Closed?
buff.ly/3dvbEyE
9
20
Adjuvant therapy in RCC : is the chapter of VEGF inhibitors definitively closed ? Check out our latest article, co-written with @FlorentPeyraud, Pr A.Ravaud and Dr M.Gross-Goupil in @EUplatinum ⤵️
@OncoAlert @CHUBordeaux @univbordeaux sciencedirect.com/science/ar…
4
15
Mathieu Larroquette retweeted
📯 Thrilled to share our latest article, now published in @EUplatinum, summarizing current data and future perspectives on adjuvant therapy in renal cell carcinoma. Many thanks to my co-author @MathieuLrqt, and Dr Gross-Goupil & Pr Ravaud for their mentorship! Here the link👇🏻
2
5
15